The article examines the objective, findings, and clinical context described in Looking Beyond Discrimination in Prehospital Scores to Improve Patient Outcomes.
Approach:
Study population: A prospective multicenter study assessed 16,106 patients using mSOFA ≥5 as the high-acuity threshold; 85 patients who died within two days had mSOFA below 5.
Secondary screen: Investigators examined relationships among mSOFA components and defined the Occult Hypoperfusion Index (OHI) as lactate × (16 − GCS). A derivation threshold of 3.38 was selected using the Youden index.
Validation: The OHI was also applied without refitting in a geographically separate Austrian cohort of 829 patients.
Key Findings:
Among false-negative patients, lactate and GCS had a strong positive association (Spearman’s ρ = 0.616); higher lactate accompanied better-preserved consciousness.
In the low-mSOFA group, OHI detected 73 of 85 deaths, increasing sensitivity for two-day mortality from 90.9% to 98.7%.
In the Austrian cohort, OHI detected four of the five deaths missed by mSOFA.
At the 3.38 threshold, specificity in the low-mSOFA subgroup was 77.0% and mortality positive predictive value was 2.4%; approximately 3,000 additional survivors screened positive.
Interpretation:
The authors describe OHI as a potential sequential safety screen for patients with mSOFA below 5. Its operational value cannot be determined from mortality detection alone; prediction of early resource use and time-critical treatment requires further study.
Limitations:
The Austrian validation included only five deaths missed by mSOFA, limiting certainty.
The low positive predictive value and large number of additional survivors screening positive raise questions about operational burden.
Prospective evaluation is needed to determine whether formal OHI use improves care.
Conclusion:
The article argues that prediction scores should be assessed not only by overall discrimination but also by which patients they miss and whether a second-line screen can identify them at an acceptable operational cost.
Caitlin Houghton, MD, is a gastrointestinal surgeon with Keck Medicine of USC who specializes in performing minimally invasive foregut and general surgery.
